Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03083366 · ClinicalTrials.gov registry record · NA
Sacral Nerve Stimulation in Improving Bladder Function After Acute Traumatic Spinal Cord Injury
A NA study, sponsored by University of Utah.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT03083366: Clinical Trial NA study, sponsored by University of Utah.
NCT03083366 is a NA study that was terminated before completion, run by University of Utah. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03083366, a NA study, was terminated before completion, sponsored by University of Utah.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to see what effects sacral neuromodulation has on bladder function and quality of life in patients with acute spinal cord injury. Within 12-weeks of injury, participants will either receive an implanted nerve stimulator (like a pace-maker for the bladder) or standard care for neurogenic bladder. Patients will be assigned to one of these groups at random and followed for one year. The hypothesis is that early stimulation of the nerves will help prevent the development of neurogenic bladder.
Primary Outcome
Maximum bladder capacity as measured by urodynamic study at 12 months
Interventions
- DEVICE PrimeAdvanced Surescan 97702 Neurostimulator - Medtronic (Minneapolis, MN)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2019-08-07 |
| Est. Completion | 2023-04-20 |
| Phase | NA |
Why NCT03083366 stopped before completion
NCT03083366 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which PrimeAdvanced Surescan 97702 Neurostimulator - Medtronic (Minneapolis, MN) is the first listed.
NCT03083366 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03083366 about?
NCT03083366 is a clinical study titled "Sacral Nerve Stimulation in Improving Bladder Function After Acute Traumatic Spinal Cord Injury". The purpose of this study is to see what effects sacral neuromodulation has on bladder function and quality of life in patients with acute spinal cord injury. Within 12-weeks of injury, participants will either receive an implanted nerve stimulator (like a pace-maker for the bladder) or standard car...
What is the current status of trial NCT03083366?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2019-08-07. Estimated completion is 2023-04-20.
What interventions are being tested in trial NCT03083366?
The interventions under investigation include: PrimeAdvanced Surescan 97702 Neurostimulator - Medtronic (Minneapolis, MN) (DEVICE).
Who is sponsoring clinical trial NCT03083366?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03083366's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI